Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 72603-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

This is a description of Daptomycin for Injection by Aspira Pharma Limited. The product comes in 500mg per vial and needs to be refrigerated before intravenous infusion using 0.9% Sodium Chloride. As per the given text, this product should be reconstituted with 10% sodium injection. Any unused portion of the product should be discarded. Unfortunately, the text doesn't contain detailed information on usage, side effects, or precautions.*

FDA Label Image

Daptomycinestructure (Daptomycinestructure)

FDA Label Image

Vial-label (Vial Label)

This is a description of Daptomycin for injection, a medication with 500mg of dosage per vial. It must be kept refrigerated and should be used for intravenous infusion only. It is sold in single-dose vials and any unused portion should be discarded. The medication should only be reconstituted with 10ml of 0.8% Sodium Chloride Injection. The user should refer to the package for complete dosage and administration information. The lot number, expiration date, and manufacturer information are specified on the label. The medication is manufactured by Aspiro Pharma Ltd. for Northstar Rx LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.